Dietary supplements based on Harpagophytum: risks and regulations

Harpagophytum: dietary supplement or medicine?
Indication and active substance
📌 Indication: joints
📌 Active substance: Harpagophytum root extract
Regulatory regime
Harpagophytum is primarily marketed as a dietary supplement. However, certain formulations and communications can lead to its reclassification as a medicine.
Risk of reclassification as a medicine
A product containing Harpagophytum extract and bearing the claim “contributes to maintaining good joint mobility” is acceptable as a food supplement.
⚠️ But be careful !
If the packaging includes a pictogram depicting joint pain or a human body with inflamed areas, the product risks being reclassified as a medicinal product by presentation.
Why?
✔️ Visuals and pictograms that suggest a therapeutic effect may be considered indicators of a medicinal positioning.
✔️ The claim “anti-inflammatory” is strictly reserved for medicines.
How to avoid reclassification ?
✔️ Remove pictograms that may suggest a medical use.
✔️ Ensure claims comply with European regulations governing the communication of food supplements.
Conclusion
Harpagophytum is a popular ingredient in food supplements, but communication must be carefully crafted to avoid reclassification as a medicinal product.
Frequently asked questions about dietary supplements based on Harpagophytum
Can I mention the anti-inflammatory benefits of Harpagophytum?
No. Anti-inflammatory claims are strictly reserved for medicines and require specific authorization.
Can a pictogram on the packaging cause problems ?
Yes. If the visual suggests a therapeutic effect, it can lead to reclassification as a medicine.